HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--June 15, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) is pleased to announce that positive results from successful clinical studies of the Company's AlzheimAlert (TM) test were presented at the International Meeting on Affective, Behavioral and Cognitive Disorders in the Elderly in Bologna, Italy on June 15. A platform presentation on independent clinical studies of the AlzheimAlert(TM) test, including data and individual case reports, was given by Dr. Ira Goodman of the Orlando Regional Healthcare System and the University of Florida School of Medicine. Dr. Goodman was a principal investigator.
